Nineteen patients with localized non-Hodgkin's lymphoma large cell type classified by the international formulation in group D ( 5 ) and group G (14) were treated with extended field radiation therapy. These patients have been followed for 168 months with range from 12 to 168 months from initiation
VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma
β Scribed by Peter Jacobs; Helen S. King; David M. Dent; Malcolm Hayes
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 868 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The International Prognostic Index (IPI) is widely used as a predictive model in diffuse large Bβcell lymphoma (DLBCL) patients of all ages and stages. To determine the optimal IPIβbased prognostic system at the time of diagnosis in younger patients with limitedβstage DLB
## BACKGROUND. Although many studies of elderly patients with non-Hodgkin lymphoma have focused on the dose intensity of chemotherapy, few studies have restricted the histologic inclusion criteria such that only patients with diffuse large B-cell lymphoma (DLCL) are considered. In the current stud